View Single Post
Old 08-23-2016, 09:08 AM
hercules957's Avatar
hercules957 hercules957 is offline
Junior Member
 
Join Date: Aug 2016
Location: Toronto
Posts: 10
5 yr Member
hercules957 hercules957 is offline
Junior Member
hercules957's Avatar
 
Join Date: Aug 2016
Location: Toronto
Posts: 10
5 yr Member
Default

Quote:
Originally Posted by jeffreyn View Post
"The cause of Parkinson’s isn’t well understood, but the reason the drug wears off is. It’s because the brain also starts losing an enzyme known as aromatic L-amino acid decarboxylase, or AADC, that is needed to convert L-Dopa into dopamine."

I've not heard this before, and I suspect it might be a technical writer's (mis)understanding, rather than the researcher's view.

However, the underlying premise seems sound to me, and they are getting some results. That is, as more neurons die, if you can boost (e.g. by gene therapy) the amount of AADC (the enzyme that catalyzes the conversion of levodopa to dopamine) in the brain, then this might boost the amount of dopamine produced by the remaining neurons.


Carbidopa does this with side effects, it would be nice to get AADC from Gene therapy combined with pure levodopa.
hercules957 is offline   Reply With QuoteReply With Quote